PLASMINOGEN  	PLASMINOGEN  	 NNP	B-NP
AND  	AND  	 CC	O
ANGIOSTATIN  	ANGIOSTATIN  	 NNP	B-NP
LEVELS  	LEVELS  	 NNP	I-NP
IN  	IN  	 IN	O
FEMALE  	FEMALE  	 NNP	O
BENIGN  	BENIGN  	 NNP	O
BREAST  	BREAST  	 NNP	O
LESIONS  	LESIONS  	 NNP	O
It  	It  	 PRP	O
is  	is  	 VBZ	O
known  	known  	 VBN	O
that  	that  	 IN	O
benign  	benign  	 JJ	O
breast  	breast  	 NN	B-NP
tissue  	tissue  	 NN	I-NP
exhibit  	exhibit  	 NN	I-NP
relatively  	relatively  	 RB	O
low  	low  	 JJ	O
angiogenic  	angiogenic  	 JJ	B-NP
capacity 	capacity 	 NN	I-NP
.  	.  	 .	O
Activation  	Activation  	 NNP	B-NP
of  	of  	 IN	I-NP
angiogenesis  	angiogenesis  	 NN	I-NP
in  	in  	 IN	O
mammary  	mammary  	 JJ	B-NP
pre-malignant  	pre-malignant  	 JJ	I-NP
lesions  	lesions  	 NNS	I-NP
could  	could  	 MD	O
be  	be  	 VB	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
disease  	disease  	 NN	B-NP
progression  	progression  	 NNS	I-NP
and  	and  	 CC	O
high  	high  	 JJ	O
risk  	risk  	 NN	O
of  	of  	 IN	O
transformation  	transformation  	 NN	B-NP
into  	into  	 IN	O
the  	the  	 DT	O
breast  	breast  	 NN	O
cancer 	cancer 	 NN	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
insight  	insight  	 VBG	O
into  	into  	 IN	O
the  	the  	 DT	O
underlying  	underlying  	 JJ	O
molecular  	molecular  	 JJ	B-NP
mechanisms  	mechanisms  	 NNS	I-NP
involved  	involved  	 VBN	O
in  	in  	 IN	O
angiogenesis  	angiogenesis  	 JJ	B-NP
regulation  	regulation  	 NN	I-NP
in  	in  	 IN	O
non-cancerous  	non-cancerous  	 JJ	B-NP
breast  	breast  	 NN	I-NP
pathologies  	pathologies  	 NN	I-NP
is  	is  	 VBZ	O
still  	still  	 RB	O
poorly  	poorly  	 RB	O
defined 	defined 	 VBN	O
.  	.  	 .	O
The  	The  	 DT	O
purpose  	purpose  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
present  	present  	 JJ	O
study  	study  	 NN	O
was  	was  	 VBD	O
to  	to  	 TO	O
determine  	determine  	 VB	O
levels  	levels  	 NNS	O
of  	of  	 IN	O
plasminogen  	plasminogen  	 NN	B-NP
and  	and  	 CC	O
its  	its  	 PRP$	O
proteolytic  	proteolytic  	 JJ	B-NP
fragments  	fragments  	 NNS	I-NP
( 	( 	 -LRB-	O
angiostatins 	angiostatins 	 LS	B-NP
)  	)  	 -RRB-	O
in  	in  	 IN	O
mammary  	mammary  	 JJ	B-NP
dysplasia  	dysplasia  	 NNS	I-NP
( 	( 	 -LRB-	O
mastopathy  	mastopathy  	 NN	B-NP
and  	and  	 CC	O
breast  	breast  	 JJ	O
cyst 	cyst 	 NN	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
benign  	benign  	 JJ	O
neoplasms  	neoplasms  	 NNS	O
( 	( 	 -LRB-	O
fibroadenomas 	fibroadenomas 	 LS	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Plasminogen  	Plasminogen  	 NNP	B-NP
and  	and  	 CC	O
angiostatins  	angiostatins  	 NNS	B-NP
were  	were  	 VBD	O
analyzed  	analyzed  	 VBN	O
using  	using  	 VBG	O
immunoblotting  	immunoblotting  	 NNS	B-NP
and  	and  	 CC	O
quantified  	quantified  	 VBN	O
by  	by  	 IN	O
densitometric  	densitometric  	 JJ	B-NP
scanning 	scanning 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
significant  	significant  	 JJ	O
increase  	increase  	 NN	O
in  	in  	 IN	O
plasminogen  	plasminogen  	 JJ	B-NP
levels  	levels  	 NNS	I-NP
was  	was  	 VBD	O
found  	found  	 VBN	O
in  	in  	 IN	O
fibrocystic 	fibrocystic 	 NN	B-NP
,  	,  	 ,	O
cysts 	cysts 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
non-proliferatious  	non-proliferatious  	 JJ	B-NP
fibroadenoma  	fibroadenoma  	 JJ	I-NP
masses  	masses  	 NNS	I-NP
( 	( 	 -LRB-	O
4.7- 	4.7- 	 NNP	O
,  	,  	 ,	O
3.7- 	3.7- 	 NNP	O
,  	,  	 ,	O
and  	and  	 CC	O
3.5-fold 	3.5-fold 	 NNP	O
,  	,  	 ,	O
respectively 	respectively 	 RB	O
)  	)  	 -RRB-	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
healthy  	healthy  	 JJ	O
breast  	breast  	 NN	O
tissues  	tissues  	 NNS	O
( 	( 	 -LRB-	O
control 	control 	 NN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
In  	In  	 IN	O
the  	the  	 DT	O
same  	same  	 JJ	O
benign  	benign  	 JJ	O
lesions 	lesions 	 NNS	O
,  	,  	 ,	O
6.7- 	6.7- 	 NNP	O
,  	,  	 ,	O
4- 	4- 	 NNP	O
,  	,  	 ,	O
and  	and  	 CC	O
3.7-fold  	3.7-fold  	 CD	O
increase  	increase  	 NN	O
in  	in  	 IN	O
plasminogen  	plasminogen  	 CD	B-NP
50  	50  	 CD	O
kDa  	kDa  	 JJ	B-NP
fragment  	fragment  	 NN	I-NP
( 	( 	 -LRB-	O
angiostatin 	angiostatin 	 LS	B-NP
)  	)  	 -RRB-	O
levels  	levels  	 NNS	O
as  	as  	 RB	O
compared  	compared  	 VBN	O
with  	with  	 IN	O
control  	control  	 NN	O
were  	were  	 VBD	O
also  	also  	 RB	O
observed 	observed 	 VBD	O
.  	.  	 .	O
Activation  	Activation  	 NNP	B-NP
of  	of  	 IN	I-NP
matrix  	matrix  	 CD	I-NP
metalloproteinase-9 	metalloproteinase-9 	 CD	I-NP
,  	,  	 ,	O
which  	which  	 WDT	O
was  	was  	 VBD	O
detected  	detected  	 VBN	O
using  	using  	 VBG	O
gelatine  	gelatine  	 JJ	B-NP
zymography 	zymography 	 NN	I-NP
,  	,  	 ,	O
could  	could  	 MD	O
be  	be  	 VB	O
responsible  	responsible  	 JJ	O
for  	for  	 IN	O
plasminogen  	plasminogen  	 JJ	B-NP
cleavage  	cleavage  	 NN	I-NP
and  	and  	 CC	O
abundance  	abundance  	 NN	B-NP
of  	of  	 IN	I-NP
angiostatin  	angiostatin  	 JJ	I-NP
infibrocystic  	infibrocystic  	 NN	I-NP
and  	and  	 CC	O
cyst  	cyst  	 JJ	O
masses 	masses 	 NNS	O
.  	.  	 .	O
In  	In  	 IN	O
contrast 	contrast 	 NN	O
,  	,  	 ,	O
dramatic  	dramatic  	 JJ	O
decrease  	decrease  	 NN	O
of  	of  	 IN	O
both  	both  	 DT	O
plasminogen  	plasminogen  	 NN	B-NP
and  	and  	 CC	O
angiostatin  	angiostatin  	 JJ	B-NP
levels  	levels  	 NNS	I-NP
( 	( 	 -LRB-	O
3.8-  	3.8-  	 NNP	O
and  	and  	 CC	O
5.3-folds 	5.3-folds 	 NNP	O
,  	,  	 ,	O
respectively 	respectively 	 RB	O
)  	)  	 -RRB-	O
was  	was  	 VBD	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
tissues  	tissues  	 NNS	O
of  	of  	 IN	O
proliferatious  	proliferatious  	 JJ	B-NP
form  	form  	 NN	I-NP
of  	of  	 IN	I-NP
fibroadenoma  	fibroadenoma  	 NN	I-NP
in  	in  	 IN	O
comparison  	comparison  	 NN	O
with  	with  	 IN	O
that  	that  	 DT	O
of  	of  	 IN	O
the  	the  	 DT	O
dormant  	dormant  	 JJ	O
type  	type  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
neoplasm 	neoplasm 	 NN	O
.  	.  	 .	O
Based  	Based  	 VBN	O
on  	on  	 IN	O
the  	the  	 DT	O
obtained  	obtained  	 JJ	O
results 	results 	 NNS	O
,  	,  	 ,	O
we  	we  	 PRP	O
concluded  	concluded  	 VBD	O
that  	that  	 DT	O
angiostatin 	angiostatin 	 NN	B-NP
,  	,  	 ,	O
a  	a  	 DT	O
potent  	potent  	 JJ	O
vessel  	vessel  	 NN	B-NP
growth  	growth  	 NN	I-NP
inhibitor  	inhibitor  	 NNS	I-NP
and  	and  	 CC	O
anti-inflammatory  	anti-inflammatory  	 JJ	B-NP
molecule 	molecule 	 NN	I-NP
,  	,  	 ,	O
can  	can  	 MD	O
play  	play  	 VB	O
a  	a  	 DT	O
crucial  	crucial  	 JJ	O
role  	role  	 NN	O
in  	in  	 IN	O
pathophysiology  	pathophysiology  	 NN	B-NP
of  	of  	 IN	I-NP
non-cancerous  	non-cancerous  	 JJ	I-NP
breast  	breast  	 NN	I-NP
diseases 	diseases 	 NNS	I-NP
.  	.  	 .	O
Further  	Further  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
are  	are  	 VBP	O
needed  	needed  	 VBN	O
to  	to  	 TO	O
evaluate  	evaluate  	 VB	O
potential  	potential  	 JJ	B-NP
diagnostic  	diagnostic  	 JJ	I-NP
and  	and  	 CC	O
clinical  	clinical  	 JJ	B-NP
implications  	implications  	 NNS	I-NP
of  	of  	 IN	O
these  	these  	 DT	O
proteins  	proteins  	 NNS	O
for  	for  	 IN	O
prediction  	prediction  	 NN	O
and  	and  	 CC	O
therapy  	therapy  	 NN	O
of  	of  	 IN	O
benign  	benign  	 JJ	O
breast  	breast  	 NN	O
pathologies 	pathologies 	 NN	O
.  	.  	 .	O
